ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Christophe Baufreton
Daniel Loisance
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirsch, M.
Right arrow Articles by Loisance, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirsch, M.
Right arrow Articles by Loisance, D.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1999;67:1623-1629
© 1999 The Society of Thoracic Surgeons

Original Articles

Pretreatment with a potassium-channel opener before prolonged cardiac storage: an evaluation in an experimental brain death model

Matthias Kirsch, MDa, Sylvie Bertrand, MDa, Jean-Paul Garnier, MDb, Christine Fernandez, PharmDa, Christophe Baufreton, MD, PhDa, Alain Astier, PharmDa, Daniel Loisance, MDa

a Centre de Recherches Chirurgicales Henri Mondor and the Pharmacie Centrale, Hôpital Henri Mondor, Créteil, France
b Department of Biochemistry, Hôpital Saint-Louis, Paris, France

Accepted for publication November 13, 1998.

Address reprint requests to Dr Loisance, Centre de Recherches Chirurgicales Henri Mondor, Faculté de Médecine, 8 rue du Générail Sarrail, 94010 Créteil Cédex, France

Background. Pretreatment with a potassium-channel opener has been shown to improve functional recovery after long-term cardioplegic arrest. We evaluated whether pretreatment with the potassium-channel opener cromakalim is beneficial in a more clinically relevant experimental model of brain death in the rabbit.

Methods. Four groups of rabbits were studied in a 2 x 2 factorial experiment (n = 8 per group). Rabbits were subjected to a sham operation or 90 minutes of brain death induced by inflating a subdurally placed balloon. Thirty minutes before heart explantation, rabbits received either no pretreatment or an intravenous injection of cromakalim, 30 µg/kg. Hearts then received 5 hours’ hypothermic storage in St. Thomas’ Hospital solution and were assessed on a buffer-perfused isolated heart preparation. Hemodynamic recovery, coronary flow, and creatine kinase release were determined after 60 minutes of reperfusion.

Results. Systolic function and diastolic function were significantly altered in hearts explanted from brain-dead rabbits compared with hearts from rabbits having a sham operation. Cromakalim pretreatment had no significant effect on poststorage systolic or diastolic function of hearts explanted from brain-dead or sham-operation rabbits. Further, cromakalim pretreatment did not affect coronary flow or overall creatine kinase release during reperfusion.

Conclusions. In vivo pretreatment of brain-dead rabbits or anesthetized rabbits with an intravenous injection of cromakalim had no significant effect on functional recovery of or enzymatic release from explanted hearts after 5 hours’ hypothermic storage and 60 minutes’ reperfusion. These findings underscore the importance of clinically relevant experimental models.


Related Article


Ann. Thorac. Surg. 67: 1630-1630. [Full Text]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 by The Society of Thoracic Surgeons.